Company page
Coherus Oncology, Inc.
Coherus Oncology, Inc. is a public company traded on the American stock market under the ticker CHRS. The company has a market capitalization of approximately $217.5 million. Coherus focuses on developing innovative therapies for cancer treatment.
- Ticker
- CHRS:NASDAQ
- Asset type
- Stock
- Market cap
- $217.8M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD